Corbus Pharmaceuticals Holdings, Inc.
NASDAQCorbus Pharmaceuticals just delivered a notable week: Q1 earnings arrived, the stock rallied more than 7%, and every analyst on the name trimmed their target anyway. That tension — a price climbing while Street estimates come down — is the defining story heading into the next leg of the CRBP trade. The Earnings Print The Q1 results landed on May 12. EPS came in…
CRBP cost to borrow surges 206% in one week to 0.49%, driven by tightening share availability as short interest rises 7.3% to 7.3% of float.
Snapshot as of 28 Jun 2026
Corbus Pharmaceuticals just delivered a notable week: Q1 earnings arrived, the stock rallied more than 7%, and every analyst on the name trimmed their target anyway. That tension — a price climbing while Street…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CRBP — free to start on ORTEX.
Sign up for free →Open CRBP on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live CRBP data →